These webinars are organised by the APSAD Smoking and Vaping Cessation Professionals (ASVCP) Special Interest Group for APSAD members, providing the opportunity to share information and knowledge through regular contact and webinars. The aim is the promotion of optimal smoking cessation practice in Australasia by trained health professionals incorporating evidence-based practice with an ongoing learning objective.
Membership of the ASVCP-SIG is open to APSAD members with an interest in Smoking and Vaping Cessation. For information contact Membership Services at This email address is being protected from spambots. You need JavaScript enabled to view it..
Coming Up in the ASVCP Webinar Series
Tuesday 10 September 2024 l 1300 (AEST)
Clinical use of biomarkers: Bringin precision medicine to smoking and vaping cessation
Presenter: Prof Renee Bittoun, Medical School, Notre Dame University and Nicotine Addiction Unit, Lifestyle Medicine, Avondale University, Sydney, NSW
Presenter: Michael Fitzpatrick, Senior Hospital Scientist, Department of Chemical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW
|
Registration Terms and Conditions Any persons affiliated with tobacco entities (current, in the past, or have future plans), tobacco lobbyists, either professionally or on a personal basis, will be ineligible to attend or present at any APSAD webinar or event. APSAD’s policy is aligned with the World Health Organization’s Framework Convention on Tobacco Control, Article 5.3: There is a fundamental and irreconcilable conflict between the tobacco industry’s interest and public health policy interests. Registrations from such persons will be cancelled without notice. Paid registrations of such persons will not be refunded. |
|
Disclaimer The views expressed by presenters and speakers are not necessarily the views of APSAD, and the Society does not accept responsibility for any information, research, recommendation or advice presented. |
-----------------------------------------------------------------------------------------------
Watch ASVCP Webinars
Previous Recordings
September 2024 l Clinical use of biomarkers: Bringing precision medicine to smoking and vaping cessation
Presenter: Prof Renee Bittoun, Medical School, Notre Dame University and Nicotine Addiction Unit, Lifestyle Medicine, Avondale University, Sydney, NSW
Presenter: Michael Fitzpatrick, Senior Hospital Scientist, Department of Chemical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW
August 2024 l Practices and insights from use of NRT products in research trials across community and health settings
This presentation will outline the use of nicotine replacement therapies as core smoking cessation intervention elements in a number of randomised controlled trials with high priority groups across various health and community setting types. Research lessons learned as well as perspectives and experiences from setting staff and volunteers will be presented.
Presenter: Dr Ashleigh Guillaumier, Senior Research Fellow, College of Medicine and Public Health, Flinders University
July 2024 l A content analysis of illicit tobacco-related crimes reported in Australian media
Australian survey and seizure data suggest a growing illicit tobacco market. As an illicit product, accurately tracking trends in illicit tobacco growing, manufacture and sales is challenging. This is the first study that has used media articles and government press releases to synthesise trends in Australia’s illicit tobacco market over the past two decades, and as such, represents the most comprehensive synthesis to date of illicit tobacco-related crimes in Australia. This presentation will explore and discuss these trends.
Presenter: Ms Isabel Meciar, PhD Candidate, NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, The University of Queensland
June 2024 l Tobacco Use in Drug and Alcohol Use Disorders: First cab off the rank or least of our problems
This webinar will cover the epidemiology and evidence base for treatment of tobacco use disorders in people with other substance use disorders. It will also cover important clinical considerations including drug-drug interactions and considerations in prioritisation of care.
Presenter: Dr Adam Pastor, Deputy Director Department Addiction Medicine, St Vincent's Hospital Melbourne
June 2024 l Trends in vaping and tobacco smoking: An Australian and Aotearoa New Zealand outlook
Presenters:
Professor Hayden McRobbie, National Drug & Alcohol Research Centre, University of New South Wales, Sydney; and Regional Director, Northern National Public Health Service, Health Board New Zealand,
Dr Ryan Courtney, Program Lead Tobacco Research Group, National Drug & Alcohol Research Centre, University of New South Wales, Sydney; Associate Professor/ National Heart Foundation Future Leader Fellow; and ASVCP Chair
April 2024 | An update on the Royal Australian College of General Practitioners (RACGP) guidance for clinicians on Therapeutic Vaping
This presentation will critique recent changes to regulation on access to vaping products and discuss use of therapeutic vaping for treatment of nicotine dependence.
Presenter: Professor Nicholas Zwar, Executive Dean, Faculty of Health Sciences and Medicine, Bond University
March 2024 | Reducing e-cigarette use among young people in NSW - social marketing campaign
This presentation will provide an overview of the NSW social marketing campaign to reduce e-cigarette use among young people (14-24 years). The presentation will focus on research and insights for campaign development
Presenters: Kate Reakes, Manager, Cancer Prevention, Cancer Screening & Prevention, Cancer Institute NSW, and Dr Sandra Rickards, Team Leader, Research & Evaluation, Cancer Screening & Prevention, Cancer Institute NSW
No recording availble for this webinar.
February 2024 | Intensive tobacco treatment incorporating contingency management for women attending substance use in pregnancy antenatal services. Is it feasible?
Pregnant women who use tobacco and other psychoactive substances are a high-priority group. Typically, considerable resources are devoted to preventing other substance use, but most women will continue to smoke tobacco throughout their pregnancy and beyond. This webinar describes the feasibility of an intensive tobacco treatment incorporating contingency management, nicotine replacement therapy and behavioural counselling into treatment for women attending substance use in pregnancy antenatal services. Included are results from the pilot trial including a cost-consequence analysis, and qualitative analysis of acceptability from the client and clinician perspective.
Presenter: Dr Melissa Jackson, Clinical Trial Coordinator, Drug and Alcohol Clinical Services Research Unit, Hunter New England Local Health District, NSW
October 2023 | Generation Vape: The explosive rise in youth vaping in Australia
Presenter: Becky Freeman, Associate Professor Becky Freeman leads a program of research focused on countering the commercial determinants of health, including tobacco, e-cigarettes, and processed food.
| WATCH THIS WEBINAR |
September 2023 | Unlocking options: The changing landscape of smoking cessation medications’ availability in Australia
Presenter: Deepali Gupta, is an advanced pharmacist, working across many complex clinical areas at QEII Hospital in Brisbane| WATCH THIS WEBINAR |
AUGUST 2023 | The teachable moment of lung cancer screening: stakeholder views and significant opportunities to offer cessation support
Presenter: Nathan Harrison PhD Candidate and Senior Research OfficerPublic Health Discipline and National Centre for Education and Training on Addiction (NCETA), College of Medicine and Public HealthFlinders University| WATCH THIS WEBINAR |
June 2023 |Vaping Trends
Presenter Prof Ryan Courtney| WATCH THIS WEBINAR |
May 2023 | The patient experiences of adults with Chronic Obstructive Pulmonary Disease (COPD) in Australian general practice
Study findings from four studies, conducted as part of the PhD thesis will be discussed. The studies broadly seek to describe and synthesise the experience of care for adults with COPD and focus on patients seeking care in the community, who continue to smoke. The first study was a secondary analysis of data from an online, nationwide survey. Next, a meta-ethnographic review of published qualitative studies and a mixed-methods narrative rapid review that described patient experiences during the COVID-19 pandemic. Finally, an Interpretative Phenomenological Analysis (IPA) to explore the healthcare experiences of patients with doctor diagnosed COPD in primary care.Presenter: Sanduni Madawala, Research Fellow/Research Assistant Department of General Practice Monash University| WATCH THIS WEBINAR |
April 2023 | Why has Australia failed to implement tobacco endgame policies and what might precipitate policy adoption?
Modelling indicates that tobacco endgame policies will rapidly reduce smoking and improve health equity. Andrew’s PhD study uses applied policy research to explore themes and framing of tobacco endgame policies for Australia. Approaches include comparative policy analysis, and analysis of media articles, public health submissions and interviews with policy stakeholders. Dominant public health models and theories of the policy process inform the research designs and data analysis.
Presenter: Andrew Perusco, PhD Student/ Sir Roland Wilson Scholar Team/Department National Centre for Aboriginal and Torres Strait Islander Wellbeing Research/ NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame
March 2023 | High-dose transdermal nicotine replacement therapy: Risk of overdose or best practice?
Nicotine Replacement Therapy (NRT) has been an approved first-line smoking cessation therapy for almost 40 years. When used in recommended doses, NRT increases the odds of a person quitting smoking. However, smokers range in nicotine plasma levels and some smokers are more highly dependent than others. So for a high nicotine dependent smoker, the recommended doses may be insufficient to manage withdrawals and “ replace” the nicotine.This presentation explores the evidence around using multiple patches concurrently, and provides some practical case studies illustrating how it can be approached.
Presenters: Prof Renee Bittoun Tobacco Treatment Specialist, Consultant, Professor, Nicotine Addiction Unit, Lifestyle Medicine, Avondale University, Australia, and the Medical School, University of Notre Dame, Australia,
Andrew Mark Health Promotion Officer, Illawarra Shoalhaven Local Health District
| WATCH THIS WEBINAR |
February 2023 | The cardiovascular risk & benefits of smoking cessation pharmacotherapies use among cardiac patients
This webinar reports the results of three population-based cohort studies. The first provides evidence on how the three smoking cessation pharmacotherapies available in Australia (NRT, varenicline and bupropion) compare to each other in terms of cardiovascular safety. The second describes the use of these pharmacotherapies among patients who hospitalised in NSW with major cardiovascular disease. Our third study compares the effectiveness of NRT and varenicline in preventing recurrent cardiovascular events.
Presenters: Dr Alys Havard, Senior Research Fellow, National Drug and Alcohol Research Centre and School of Population Health, UNSW Sydney
Dr Annelies Robijn, Postdoctoral Research Fellow National Drug and Alcohol Research Centre, UNSW Sydney.
| WATCH THIS WEBINAR |
January 2023 | Smoking Cessation for Hospitalised Patients - Do We Have Time to Intervene?
In the first ASCP webinar of 2023 Associate Professor Ben Kwan will review the concept of hospital based smoking intervention, different approaches and model of care. Along with the role of different health professional groups within the acute care setting to aid in smoking cessation.
Presenter A/Prof Benjamin Kwan, Senior Staff Specialist, St Vincent's Hospital, Sydney & Sutherland Hospital| WATCH THIS WEBINAR |
December 2022 |Let's talk about smoking Smokefree Healthcare in Mental Health Services
Mental health alcohol and other drug (MHAOD) services are well positioned to provide smoking cessation care to people experiencing mental illness however, the delivery of routine evidence-based care has not been easily achieved. This webinar will describe the practice change undertaken in Queensland to implement routine smoking cessation care across Queensland public adult MHAOD services and the partnership developed with Quitline Queensland to provide an intensive Quit program. The presentation will provide statewide outcomes, offer reflections on strengths and challenges, and provide a brief introduction to future initiatives.
Presenter: Sally Plever, is a Psychologist. She currently co-manages the Queensland Health Mental Health Clinical Collaborative (Qld MHCC), a statewide initiative for clinical service improvement in adult mental health, alcohol and other drug services
| WATCH THIS WEBINAR |
November 2022 | Escape the Vape: Supporting Adolescents and Young Adults Quit Vapes
To download a copy of the presentation slides, click here
For resources for clinicians working with adolescents, click here
August 2022 |What's in a vape: Implications for the regulation of electronic cigarettes in Australia
Australian regulation of electronic cigarettes and the scheduling of nicotine for use in these devices has recently changed (October 2021). Jody's research involves the examination of the content and toxicity of electronic cigarette liquids and aerosols.
Presenter: Dr Jody Moller (Morgan), is a lab-based toxicology researcher whose research interests sit at the intersection of analytical chemistry and public health with a focus on harm reduction methods. Her current research is focused on electronic cigarettes, cannabis and pill-testing, with particular emphasis on identification and quantification of chemical constituents in samples available to Australian consumers.
| WATCH THIS WEBINAR |
June 2022 | Indigenous excellence in reducing smoking prevalence
Presenter: Dr Raglan Maddox’s (Modewa Clan, Papua New Guinea) program of research has focused on Indigenous tobacco.
There have been significant declines reducing tobacco use. In 2018–19, 40.2% of Aboriginal and Torres Strait Islander adults were smoking daily. This reflects a 9.8% absolute decrease in prevalence since 2004–05 (50.0%) and representing almost 50,000 fewer Aboriginal and Torres Strait Islander smokers than if prevalence remained unchanged. What lessons can we take from Indigenous tobacco control since 2004-05 and where to from here?
May 2022 | Smoke in clinician's eyes - missing foetal nicotine exposure
Presenter:Angela Ratsch is a registered nurse and midwife with a particular interest in the neonatal outcomes from exposure to tobacco and nicotine pre-conceptionally and during gestation
In Australia, the maternal use of cigarettes is recorded twice across the nine months of pregnancy, however the maternal use of NRT and/or other cigarette and nicotine alternatives such as e-cigarettes, heat-not-burn tobacco, nicotine spray, mist, lozenges, gum and patches, hookahs, and chewed tobacco products is not collected. In addition, the paternal and house-hold use of tobacco and nicotine products is not recorded, thus maternal second-hand tobacco and nicotine exposure is not captured. This knowledge vacuum results in maternal and foetal tobacco and nicotine exposure misclassification and ramifications in the estimation of adverse maternal, paternal, foetal and neonatal outcomes from tobacco and nicotine exposure.
April 2022 | 5 risk free behavioural strategies to manage cravings quickly
Presenter: James McLennan, State-Wide Smoking Cessation Training Co-ordinator, Alcohol and Drug Service, St Vincent’s Hospital, Sydney
Do you have clients and patients struggling when they experience cravings? Are you to finding it hard to offer practical, realistic strategies that work when cravings arise?
Here we inform of:
-
Five strategies that are risk free, cheap or cost free
-
Strategies that are easy to learn and apply yet grounded in science
-
Strategies that you can easily teach even if you are time-limited
March 2022 | An update on the Royal Australian College of General Practitioners (RACGP) guidance on the role of Nicotine Vaping Products in smoking cessationPresenter: Professor Nick Zwar, Bond University and Chair of Expert Advisory Group for the publication An update on the Royal Australian College of General Practitioners (RACGP) guidance for smoking cessation.
This presentation will critique new changes to the regulation of nicotine as per new rescheduling of nicotine e-liquids and outline revised recommendations and practice points.
| WATCH THIS WEBINAR |
August 2020 | An Evaluation of Online and Automated Smoking Cessation Programs
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
December 2019 | What is EVALI? What we do and do not know about the vaping lung cases in the USA
| WATCH THIS WEBINAR |
This presentation will provide an overview of the EVALI “outbreak”, placing it in the context of the research evidence of the safety of nicotine vaping, the communications and media reporting used to inform the public about EVALI, and the potential consequences of misinformation.September 2019 | Let's not get burnt all over again: ill effects of electronic smoking devices
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
In this webinar, we bring together our extensive research findings as well as world studies to provide an overview of what women are experiencing - what the evidence is saying – and where to from here, in order to reduce the harms of smoking among pregnant women. Hear from GP research fellow and Tobacco Treatment Specialist A/Prof Gillian Gould, and Dr Ratika Kumar a dentist specialising in smoking cessation research in high-priority populations.
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
Presenter: Anke van der Sterren, Research Fellow, University of MelbourneThis webinar will discuss how a strategic and coordinated program of tobacco control activities by ACT alcohol and other drug (AOD) services—including targeted smoking cessation support to disadvantaged smokers—has led to significant changes in tobacco management policies, treatment practices, attitudes and smoking behaviours among service users, workers and AOD organisations. October 2018 | Cytisine for Smoking Cessation
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
| WATCH THIS WEBINAR |
For further details on the ASCP-SIGs, visit our webpage.DISCLAIMER
The views expressed by presenters and speakers are not necessarily the views of APSAD, and the Society does not accept responsibility for any information, research, recommendation or advice presented.